We are interested in how gynaecological risk reducing surgeries are positioned as a form of prevention in public discourse, clinic practice and lived experiences of BRCA and Lynch syndrome hereditary cancer conditions.
How is gynaecological cancer prevention articulated and understood in the public domain?
What social and cultural aspects about women’s bodies and health feature in content about gynaecological risk reducing surgeries? Do social media platforms, with their norms, economies and algorithms influence what stakeholders and discussions gain traction in the public domain?
How is gynaecological cancer prevention recommended in clinical practice?
What are the guidelines for gynaecological cancer prevention in the NHS context? Are gynaecological risk reducing surgeries positioned as routine and how is this positioning interpreted in practice?
What is the lived experience of undertaking or rejecting gynaecological risk reducing surgeries?
How do those with an increased risk of gynaecological cancers, like carriers of BRCA and Lynch syndrome genetic mutations, cope with, and make decisions about, cancer prevention?